Cargando…

Association Between Daily Worry, Pathological Worry, and Fear of Progression in Patients With Cancer

Background: Fear of progression (FoP), or fear of cancer recurrence (FCR), is characterized by worries or concerns about negative illness-related future events. Actually, to worry is a common cognitive process that, in its non-pathological form, belongs to daily life. However, worry can also become...

Descripción completa

Detalles Bibliográficos
Autores principales: Dinkel, Andreas, Marten-Mittag, Birgitt, Kremsreiter, Katrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384960/
https://www.ncbi.nlm.nih.gov/pubmed/34456783
http://dx.doi.org/10.3389/fpsyg.2021.648623
_version_ 1783742002709397504
author Dinkel, Andreas
Marten-Mittag, Birgitt
Kremsreiter, Katrin
author_facet Dinkel, Andreas
Marten-Mittag, Birgitt
Kremsreiter, Katrin
author_sort Dinkel, Andreas
collection PubMed
description Background: Fear of progression (FoP), or fear of cancer recurrence (FCR), is characterized by worries or concerns about negative illness-related future events. Actually, to worry is a common cognitive process that, in its non-pathological form, belongs to daily life. However, worry can also become pathological appearing as a symptom of mental disorders. This study aimed at investigating the associations among daily worry, pathological worry, and FoP in patients with cancer. Methods: This is a cross-sectional study that includes 328 hospitalized patients with cancer. Patients filled out the FoP Questionnaire (FoP-Q), the Worry Domains Questionnaire (WDQ) for the assessment of daily worry, and the Penn State Worry Questionnaire (PSWQ) for the assessment of pathological worry. Depressive, anxiety, and somatic symptoms were measured with modules of the Patient Health Questionnaire [Patient Health Questionnaire-Depressive Symptoms (PHQ-2), Generalized Anxiety Disorder-2 (GAD-2), and Patient Health Questionnaire-Somatic Symptoms (PHQ-15)]. Furthermore, a structured clinical interview was conducted for the assessment of anxiety disorders. The hierarchical multiple linear regression analysis was used to identify factors independently associated with FoP. Results: Mean age of the participants was M = 58.5 years (SD = 12.8), and 64.6% were men. FoP and worry were significantly intercorrelated (r = 0.58–0.78). The level of FoP was most strongly associated with daily worry (β = 0.514, p < 0.001), followed by pathological worry (β = 0.221, p < 0.001). Further significant determinants were younger age and depressive and anxiety symptoms. Clinical variables were not independently associated with FoP. The final model explained 74% of the variance. Discussion: Fear of progression is strongly associated with daily worry and pathological worry. These results bring up the question of whether FoP is an expression of a general tendency to worry. Whether a general tendency to worry, in fact, represents an independent vulnerability factor for experiencing FCR/FoP needs to be investigated in a longitudinal research design.
format Online
Article
Text
id pubmed-8384960
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83849602021-08-26 Association Between Daily Worry, Pathological Worry, and Fear of Progression in Patients With Cancer Dinkel, Andreas Marten-Mittag, Birgitt Kremsreiter, Katrin Front Psychol Psychology Background: Fear of progression (FoP), or fear of cancer recurrence (FCR), is characterized by worries or concerns about negative illness-related future events. Actually, to worry is a common cognitive process that, in its non-pathological form, belongs to daily life. However, worry can also become pathological appearing as a symptom of mental disorders. This study aimed at investigating the associations among daily worry, pathological worry, and FoP in patients with cancer. Methods: This is a cross-sectional study that includes 328 hospitalized patients with cancer. Patients filled out the FoP Questionnaire (FoP-Q), the Worry Domains Questionnaire (WDQ) for the assessment of daily worry, and the Penn State Worry Questionnaire (PSWQ) for the assessment of pathological worry. Depressive, anxiety, and somatic symptoms were measured with modules of the Patient Health Questionnaire [Patient Health Questionnaire-Depressive Symptoms (PHQ-2), Generalized Anxiety Disorder-2 (GAD-2), and Patient Health Questionnaire-Somatic Symptoms (PHQ-15)]. Furthermore, a structured clinical interview was conducted for the assessment of anxiety disorders. The hierarchical multiple linear regression analysis was used to identify factors independently associated with FoP. Results: Mean age of the participants was M = 58.5 years (SD = 12.8), and 64.6% were men. FoP and worry were significantly intercorrelated (r = 0.58–0.78). The level of FoP was most strongly associated with daily worry (β = 0.514, p < 0.001), followed by pathological worry (β = 0.221, p < 0.001). Further significant determinants were younger age and depressive and anxiety symptoms. Clinical variables were not independently associated with FoP. The final model explained 74% of the variance. Discussion: Fear of progression is strongly associated with daily worry and pathological worry. These results bring up the question of whether FoP is an expression of a general tendency to worry. Whether a general tendency to worry, in fact, represents an independent vulnerability factor for experiencing FCR/FoP needs to be investigated in a longitudinal research design. Frontiers Media S.A. 2021-08-11 /pmc/articles/PMC8384960/ /pubmed/34456783 http://dx.doi.org/10.3389/fpsyg.2021.648623 Text en Copyright © 2021 Dinkel, Marten-Mittag and Kremsreiter. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychology
Dinkel, Andreas
Marten-Mittag, Birgitt
Kremsreiter, Katrin
Association Between Daily Worry, Pathological Worry, and Fear of Progression in Patients With Cancer
title Association Between Daily Worry, Pathological Worry, and Fear of Progression in Patients With Cancer
title_full Association Between Daily Worry, Pathological Worry, and Fear of Progression in Patients With Cancer
title_fullStr Association Between Daily Worry, Pathological Worry, and Fear of Progression in Patients With Cancer
title_full_unstemmed Association Between Daily Worry, Pathological Worry, and Fear of Progression in Patients With Cancer
title_short Association Between Daily Worry, Pathological Worry, and Fear of Progression in Patients With Cancer
title_sort association between daily worry, pathological worry, and fear of progression in patients with cancer
topic Psychology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384960/
https://www.ncbi.nlm.nih.gov/pubmed/34456783
http://dx.doi.org/10.3389/fpsyg.2021.648623
work_keys_str_mv AT dinkelandreas associationbetweendailyworrypathologicalworryandfearofprogressioninpatientswithcancer
AT martenmittagbirgitt associationbetweendailyworrypathologicalworryandfearofprogressioninpatientswithcancer
AT kremsreiterkatrin associationbetweendailyworrypathologicalworryandfearofprogressioninpatientswithcancer